India’s Covaxin led to tolerable safety outcomes and enhanced immune responses: Lancet

India’s Covaxin led to tolerable safety outcomes and enhanced immune responses: Lancet According to the Lancet, all adverse events were mild and moderate and were more frequent after the first dose. https://ift.tt/eA8V8J